These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4324447)

  • 1. Clinical biostatistics. 8. An analytic appraisal of the University Group Diabetes Program (UGDP) study.
    Feinstein AR
    Clin Pharmacol Ther; 1971; 12(2):167-91. PubMed ID: 4324447
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical biostatistics. XXXV. The persistent clinical failures and fallacies of the UGDP study.
    Feinstein AR
    Clin Pharmacol Ther; 1976 Jan; 19(1):78-93. PubMed ID: 1106937
    [No Abstract]   [Full Text] [Related]  

  • 3. How good is the statistical evidence against oral hypoglycemic agents?
    Feinstein AR
    Adv Intern Med; 1979; 24():71-95. PubMed ID: 371369
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
    Prout TE
    Med Clin North Am; 1971 Jul; 55(4):1065-75. PubMed ID: 4946757
    [No Abstract]   [Full Text] [Related]  

  • 6. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 7. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 8. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
    Teuscher A
    Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
    [No Abstract]   [Full Text] [Related]  

  • 9. The UGDP controversy. Clinical trials versus clinical impressions.
    Prout TE; Knatterud GL; Meinert CL; Klimt CR
    Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
    [No Abstract]   [Full Text] [Related]  

  • 10. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical biostatistics. XXXVI. the persistent biometric problems of the UGDP study.
    Feinstein AR
    Clin Pharmacol Ther; 1976 Apr; 19(4):742-85. PubMed ID: 1269199
    [No Abstract]   [Full Text] [Related]  

  • 12. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
    Pirart J
    Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
    [No Abstract]   [Full Text] [Related]  

  • 13. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
    Seltzer HS
    Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
    [No Abstract]   [Full Text] [Related]  

  • 14. Avoiding the pitfalls of long-term therapeutic trials: lessons learned from the UGDP study.
    Seltzer HS
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):393-8. PubMed ID: 4627326
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
    Schor SS
    Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of the University Group Diabetes Study Program: data results and conslusions.
    Leibel B
    Can Med Assoc J; 1971 Aug; 105(3):292-4. PubMed ID: 5563349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.